Following the FDA’s decision on Orexigen’s Contrave, the question is: Will a successful obesity drug market ever develop?
Use this report to:
Understand the state of play with Orexigen’s Contrave
Review the prevalence and impact of obesity
Evaluate the therapeutic approaches being undertaken
Critically assess and compare the approach and potential of products in clinical research with our unique product scoring